{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:51:56Z","timestamp":1792173116743,"version":"4.4.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Med"],"DOI":"10.1038\/s43856-025-00934-3","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T18:24:42Z","timestamp":1750098282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort"],"prefix":"10.1038","volume":"5","author":[{"given":"Anastasiya","family":"Yudina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagdas","family":"Tazearslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur","family":"Baisangurov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Nuzhdina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley","family":"Lauziere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitaly","family":"Segodin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Podsvirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Starikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison","family":"Chasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-2153-8565","authenticated-orcid":false,"given":"Kirill","family":"Shaposhnikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leznath","family":"Kaneunyenye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesia","family":"Klimchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Kuzkina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2505-3846","authenticated-orcid":false,"given":"Gleb","family":"Khegai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Sookiasian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Shafranskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Lozinsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Sobolev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Abdou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Turova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Chernyshov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexey","family":"Efremov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Andrewes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviva","family":"Feinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianna","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica H.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4627-3138","authenticated-orcid":false,"given":"Anna","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Curran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2434-4978","authenticated-orcid":false,"given":"Jochen","family":"Lennerz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8680-854X","authenticated-orcid":false,"given":"Alexander","family":"Bagaev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"934_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1038\/nbt.2696","volume":"31","author":"GM Frampton","year":"2013","unstructured":"Frampton, G. M. et al. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing. Nat. Biotechnol. 31, 1023\u20131031 (2013).","journal-title":"Nat. Biotechnol."},{"key":"934_CR2","doi-asserted-by":"publisher","first-page":"153760","DOI":"10.1016\/j.prp.2022.153760","volume":"230","author":"BM Hussen","year":"2022","unstructured":"Hussen, B. M. et al. The emerging roles of NGS in clinical oncology and personalized medicine. Pathol. Res. Pract. 230, 153760 (2022).","journal-title":"Pathol. Res. Pract."},{"key":"934_CR3","doi-asserted-by":"publisher","first-page":"e000147","DOI":"10.1136\/jitc-2019-000147","volume":"8","author":"DM Merino","year":"2020","unstructured":"Merino, D. M. et al. Establishing guidelines to harmonize tumor mutational burden (TMB): in silico assessment of variation in TMB quantification across diagnostic platforms: phase I of the Friends of Cancer Research TMB Harmonization Project. J. Immunother. Cancer 8, e000147 (2020).","journal-title":"J. Immunother. Cancer"},{"key":"934_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s40246-015-0044-0","volume":"9","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. Copy number alterations detected by whole-exome and whole-genome sequencing of esophageal adenocarcinoma. Hum. Genomics 9, 22 (2015).","journal-title":"Hum. Genomics"},{"key":"934_CR5","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jmoldx.2016.09.011","volume":"19","author":"R Luthra","year":"2017","unstructured":"Luthra, R. et al. A targeted high-throughput next-generation sequencing panel for clinical screening of mutations, gene amplifications, and fusions in solid Tumors. J. Mol. Diagn. JMD 19, 255\u2013264 (2017).","journal-title":"J. Mol. Diagn. JMD"},{"key":"934_CR6","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.jmoldx.2014.09.008","volume":"17","author":"C Grasso","year":"2015","unstructured":"Grasso, C. et al. Assessing copy number alterations in targeted, amplicon-based next-generation sequencing data. J. Mol. Diagn. JMD 17, 53\u201363 (2015).","journal-title":"J. Mol. Diagn. JMD"},{"key":"934_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1755-8794-7-20","volume":"7","author":"MD Linderman","year":"2014","unstructured":"Linderman, M. D. et al. Analytical validation of whole exome and whole genome sequencing for clinical applications. BMC Med. Genomics 7, 20 (2014).","journal-title":"BMC Med. Genomics"},{"key":"934_CR8","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.jmoldx.2018.06.007","volume":"20","author":"KO Wrzeszczynski","year":"2018","unstructured":"Wrzeszczynski, K. O. et al. Analytical validation of clinical whole-genome and transcriptome sequencing of patient-derived tumors for reporting targetable variants in cancer. J. Mol. Diagn. 20, 822\u2013835 (2018).","journal-title":"J. Mol. Diagn."},{"key":"934_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.25","volume":"3","author":"JM Zook","year":"2016","unstructured":"Zook, J. M. et al. Extensive sequencing of seven human genomes to characterize benchmark reference materials. Sci. Data 3, 160025 (2016).","journal-title":"Sci. Data"},{"key":"934_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/npjgenmed.2016.19","volume":"1","author":"H Rennert","year":"2016","unstructured":"Rennert, H. et al. Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care. NPJ Genomic Med. 1, 16019 (2016).","journal-title":"NPJ Genomic Med."},{"key":"934_CR11","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.jmoldx.2021.04.011","volume":"23","author":"P Roepman","year":"2021","unstructured":"Roepman, P. et al. Clinical validation of whole genome sequencing for cancer diagnostics. J. Mol. Diagn. JMD 23, 816\u2013833 (2021).","journal-title":"J. Mol. Diagn. JMD"},{"key":"934_CR12","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1038\/s41587-019-0259-z","volume":"37","author":"N Beaubier","year":"2019","unstructured":"Beaubier, N. et al. Integrated genomic profiling expands clinical options for patients with cancer. Nat. Biotechnol. 37, 1351\u20131360 (2019).","journal-title":"Nat. Biotechnol."},{"key":"934_CR13","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray, N. L., Pimentel, H., Melsted, P. & Pachter, L. Near-optimal probabilistic RNA-seq quantification. Nat. Biotechnol. 34, 525\u2013527 (2016).","journal-title":"Nat. Biotechnol."},{"key":"934_CR14","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev, A. et al. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell 39, 845\u2013865.e7 (2021).","journal-title":"Cancer Cell"},{"key":"934_CR15","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1093\/bioinformatics\/btu548","volume":"30","author":"A Szolek","year":"2014","unstructured":"Szolek, A. et al. OptiType: precision HLA typing from next-generation sequencing data. Bioinforma. Oxf. Engl. 30, 3310\u20133316 (2014).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"934_CR16","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591\u2013594 (2018).","journal-title":"Nat. Methods"},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/bioinformatics\/btv710","volume":"32","author":"X Chen","year":"2016","unstructured":"Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. Bioinforma. Oxf. Engl. 32, 1220\u20131222 (2016).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"934_CR18","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/bioinformatics\/bty849","volume":"35","author":"T Dunn","year":"2019","unstructured":"Dunn, T. et al. Pisces: an accurate and versatile variant caller for somatic and germline next-generation sequencing data. Bioinforma. Oxf. Engl. 35, 1579\u20131581 (2019).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"934_CR19","volume-title":"Genomics in the Cloud: Using Docker, GATK, and WDL in Terra","author":"GVder Auwera","year":"2020","unstructured":"Auwera, G. Vder & O\u2019Connor, B. D. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra. (O\u2019Reilly, Beijing Boston Farnham Sebastopol Tokyo, 2020)."},{"key":"934_CR20","unstructured":"Illumina. DRAGEN secondary analysis (Version 4.3) [Computer software]. https:\/\/www.illumina.com\/products\/by-type\/informatics-products\/dragen-secondary-analysis.html (2024)."},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1093\/bioinformatics\/btt755","volume":"30","author":"B Niu","year":"2014","unstructured":"Niu, B. et al. MSIsensor: microsatellite instability detection using paired tumor-normal sequence data. Bioinforma. Oxf. Engl. 30, 1015\u20131016 (2014).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"934_CR22","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/giab008","volume":"10","author":"P Danecek","year":"2021","unstructured":"Danecek, P. et al. Twelve years of SAMtools and BCFtools. GigaScience 10, giab008 (2021).","journal-title":"GigaScience"},{"key":"934_CR23","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"934_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"934_CR25","doi-asserted-by":"publisher","first-page":"e131","DOI":"10.1093\/nar\/gkw520","volume":"44","author":"R Shen","year":"2016","unstructured":"Shen, R. & Seshan, V. E. FACETS: allele-specific copy number and clonal heterogeneity analysis tool for high-throughput DNA sequencing. Nucleic Acids Res. 44, e131\u2013e131 (2016).","journal-title":"Nucleic Acids Res."},{"key":"934_CR26","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/j.ccell.2022.07.006","volume":"40","author":"A Zaitsev","year":"2022","unstructured":"Zaitsev, A. et al. Precise reconstruction of the TME using bulk RNA-seq and a machine learning algorithm trained on artificial transcriptomes. Cancer Cell 40, 879\u2013894.e16 (2022).","journal-title":"Cancer Cell"},{"key":"934_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian, J. et al. Toil enables reproducible, open source, big biomedical data analyses. Nat. Biotechnol. 35, 314\u2013316 (2017).","journal-title":"Nat. Biotechnol."},{"key":"934_CR28","doi-asserted-by":"publisher","first-page":"D766","DOI":"10.1093\/nar\/gky955","volume":"47","author":"A Frankish","year":"2019","unstructured":"Frankish, A. et al. GENCODE reference annotation for the human and mouse genomes. Nucleic Acids Res. 47, D766\u2013D773 (2019).","journal-title":"Nucleic Acids Res."},{"key":"934_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-019-3247-x","volume":"20","author":"ZB Abrams","year":"2019","unstructured":"Abrams, Z. B., Johnson, T. S., Huang, K., Payne, P. R. O. & Coombes, K. A protocol to evaluate RNA sequencing normalization methods. BMC Bioinformatics 20, 679 (2019).","journal-title":"BMC Bioinformatics"},{"key":"934_CR30","doi-asserted-by":"crossref","unstructured":"Haas, B. J. et al. Accuracy assessment of fusion transcript detection via read-mapping and de novo fusion transcript assembly-based methods. Genome Biol. 20, 213 (2019).","DOI":"10.1186\/s13059-019-1842-9"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"100467","DOI":"10.1016\/j.crmeth.2023.100467","volume":"3","author":"BJ Haas","year":"2023","unstructured":"Haas, B. J. et al. Targeted in silico characterization of fusion transcripts in tumor and normal tissues via FusionInspector. Cell Rep. Methods 3, 100467 (2023).","journal-title":"Cell Rep. Methods"},{"key":"934_CR32","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1101\/gr.257246.119","volume":"31","author":"S Uhrig","year":"2021","unstructured":"Uhrig, S. et al. Accurate and efficient detection of gene fusions from RNA sequencing data. Genome Res. 31, 448\u2013460 (2021).","journal-title":"Genome Res."},{"key":"934_CR33","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/nmeth.3364","volume":"12","author":"DA Bolotin","year":"2015","unstructured":"Bolotin, D. A. et al. MiXCR: software for comprehensive adaptive immunity profiling. Nat. Methods 12, 380\u2013381 (2015).","journal-title":"Nat. Methods"},{"key":"934_CR34","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1101\/gr.210500.116","volume":"27","author":"MA Eberle","year":"2017","unstructured":"Eberle, M. A. et al. A reference data set of 5.4 million phased human variants validated by genetic inheritance from sequencing a three-generation 17-member pedigree. Genome Res. 27, 157\u2013164 (2017).","journal-title":"Genome Res."},{"key":"934_CR35","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L","volume":"78","author":"AF Gazdar","year":"1998","unstructured":"Gazdar, A. F. et al. Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer 78, 766\u2013774 (1998).","journal-title":"Int. J. Cancer"},{"key":"934_CR36","first-page":"3237","volume":"58","author":"GE Tomlinson","year":"1998","unstructured":"Tomlinson, G. E. et al. Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier. Cancer Res 58, 3237\u20133242 (1998).","journal-title":"Cancer Res"},{"key":"934_CR37","first-page":"2528","volume":"55","author":"DJ Easty","year":"1995","unstructured":"Easty, D. J. et al. Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression. Cancer Res. 55, 2528\u20132532 (1995).","journal-title":"Cancer Res."},{"key":"934_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/jcb.240630505","volume":"24","author":"RM Phelps","year":"1996","unstructured":"Phelps, R. M. et al. NCI-navy medical oncology branch cell line data base. J. Cell. Biochem. Suppl. 24, 32\u201391 (1996).","journal-title":"J. Cell. Biochem. Suppl."},{"key":"934_CR39","first-page":"1751","volume":"41","author":"MG Brattain","year":"1981","unstructured":"Brattain, M. G., Fine, W. D., Khaled, F. M., Thompson, J. & Brattain, D. E. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 41, 1751\u20131756 (1981).","journal-title":"Cancer Res."},{"key":"934_CR40","first-page":"467","volume":"36","author":"B Drewinko","year":"1976","unstructured":"Drewinko, B., Romsdahl, M. M., Yang, L. Y., Ahearn, M. J. & Trujillo, J. M. Establishment of a human carcinoembryonic antigen-producing colon adenocarcinoma cell line. Cancer Res. 36, 467\u2013475 (1976).","journal-title":"Cancer Res."},{"key":"934_CR41","first-page":"1020","volume":"39","author":"DL Dexter","year":"1979","unstructured":"Dexter, D. L., Barbosa, J. A. & Calabresi, P. N,N-dimethylformamide-induced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res. 39, 1020\u20131025 (1979).","journal-title":"Cancer Res."},{"key":"934_CR42","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0165-4608(02)00670-2","volume":"141","author":"A Mart\u00ednez-Ram\u00edrez","year":"2003","unstructured":"Mart\u00ednez-Ram\u00edrez, A. et al. Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques. Cancer Genet. Cytogenet. 141, 138\u2013142 (2003).","journal-title":"Cancer Genet. Cytogenet."},{"key":"934_CR43","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/bjc.1970.89","volume":"24","author":"CC Rigby","year":"1970","unstructured":"Rigby, C. C. & Franks, L. M. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br. J. Cancer 24, 746\u2013754 (1970).","journal-title":"Br. J. Cancer"},{"key":"934_CR44","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1699-0463.1968.tb03502.x","volume":"74","author":"J Pont\u00e9n","year":"1968","unstructured":"Pont\u00e9n, J. & Macintyre, E. H. Long term culture of normal and neoplastic human glia. Acta Pathol. Microbiol. Scand. 74, 465\u2013486 (1968).","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"934_CR45","first-page":"1131","volume":"21","author":"EY Lasfargues","year":"1958","unstructured":"Lasfargues, E. Y. & Ozzello, L. Cultivation of human breast carcinomas. J. Natl. Cancer Inst. 21, 1131\u20131147 (1958).","journal-title":"J. Natl. Cancer Inst."},{"key":"934_CR46","doi-asserted-by":"publisher","first-page":"11477","DOI":"10.1074\/jbc.271.19.11477","volume":"271","author":"KA Quinn","year":"1996","unstructured":"Quinn, K. A. et al. Insulin-like growth factor expression in human cancer cell lines. J. Biol. Chem. 271, 11477\u201311483 (1996).","journal-title":"J. Biol. Chem."},{"key":"934_CR47","doi-asserted-by":"publisher","unstructured":"Fogh, J. & Trempe, G. New Human Tumor Cell Lines. In Human Tumor Cells In Vitro (ed. Fogh, J.) 115\u2013159 (Springer US, https:\/\/doi.org\/10.1007\/978-1-4757-1647-4_5 1975).","DOI":"10.1007\/978-1-4757-1647-4_5"},{"key":"934_CR48","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.2910260208","volume":"26","author":"S Tsuchiya","year":"1980","unstructured":"Tsuchiya, S. et al. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int. J. Cancer 26, 171\u2013176 (1980).","journal-title":"Int. J. Cancer"},{"key":"934_CR49","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ajhg.2011.02.004","volume":"88","author":"CD Campbell","year":"2011","unstructured":"Campbell, C. D. et al. Population-genetic properties of differentiated human copy-number polymorphisms. Am. J. Hum. Genet. 88, 317\u2013332 (2011).","journal-title":"Am. J. Hum. Genet."},{"key":"934_CR50","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/nature05329","volume":"444","author":"R Redon","year":"2006","unstructured":"Redon, R. et al. Global variation in copy number in the human genome. Nature 444, 444\u2013454 (2006).","journal-title":"Nature"},{"key":"934_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-98869-x","volume":"11","author":"GA R\u00e1cz","year":"2021","unstructured":"R\u00e1cz, G. A., Nagy, N., T\u00f3v\u00e1ri, J., Ap\u00e1ti, \u00c1. & V\u00e9rtessy, B. G. Identification of new reference genes with stable expression patterns for gene expression studies using human cancer and normal cell lines. Sci. Rep. 11, 19459 (2021).","journal-title":"Sci. Rep."},{"key":"934_CR52","doi-asserted-by":"publisher","first-page":"e0144528","DOI":"10.1371\/journal.pone.0144528","volume":"10","author":"E Olsson","year":"2015","unstructured":"Olsson, E. et al. Mutation screening of 1237 cancer genes across six model cell lines of basal-like breast cancer. PLoS ONE 10, e0144528 (2015).","journal-title":"PLoS ONE"},{"key":"934_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/srep24607","volume":"6","author":"DW Craig","year":"2016","unstructured":"Craig, D. W. et al. A somatic reference standard for cancer genome sequencing. Sci. Rep. 6, 24607 (2016).","journal-title":"Sci. Rep."},{"key":"934_CR54","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.trecan.2019.11.006","volume":"6","author":"D Mandelker","year":"2020","unstructured":"Mandelker, D. & Ceyhan-Birsoy, O. Evolving significance of tumor-normal sequencing in cancer care. Trends Cancer 6, 31\u201339 (2020).","journal-title":"Trends Cancer"},{"key":"934_CR55","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.5858\/2007-131-1805-THFGEA","volume":"131","author":"F Medeiros","year":"2007","unstructured":"Medeiros, F., Rigl, C. T., Anderson, G. G., Becker, S. H. & Halling, K. C. Tissue handling for genome-wide expression analysis: a review of the issues, evidence, and opportunities. Arch. Pathol. Lab. Med. 131, 1805\u20131816 (2007).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"934_CR56","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.yexmp.2011.09.013","volume":"92","author":"G Turashvili","year":"2012","unstructured":"Turashvili, G. et al. Nucleic acid quantity and quality from paraffin blocks: defining optimal fixation, processing and DNA\/RNA extraction techniques. Exp. Mol. Pathol. 92, 33\u201343 (2012).","journal-title":"Exp. Mol. Pathol."},{"key":"934_CR57","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1101\/gr.189621.115","volume":"25","author":"M Cieslik","year":"2015","unstructured":"Cieslik, M. et al. The use of exome capture RNA-seq for highly degraded RNA with application to clinical cancer sequencing. Genome Res. 25, 1372\u20131381 (2015).","journal-title":"Genome Res."},{"key":"934_CR58","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s42003-024-06020-z","volume":"7","author":"N Kotlov","year":"2024","unstructured":"Kotlov, N. et al. Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data. Commun. Biol. 7, 392 (2024).","journal-title":"Commun. Biol."},{"key":"934_CR59","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/nrg3642","volume":"15","author":"D Sims","year":"2014","unstructured":"Sims, D., Sudbery, I., Ilott, N. E., Heger, A. & Ponting, C. P. Sequencing depth and coverage: key considerations in genomic analyses. Nat. Rev. Genet. 15, 121\u2013132 (2014).","journal-title":"Nat. Rev. Genet."},{"key":"934_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-022-02803-x","volume":"23","author":"C Xiao","year":"2022","unstructured":"Xiao, C. et al. Personalized genome assembly for accurate cancer somatic mutation discovery using tumor-normal paired reference samples. Genome Biol. 23, 237 (2022).","journal-title":"Genome Biol."},{"key":"934_CR61","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-244","volume":"15","author":"H Xu","year":"2014","unstructured":"Xu, H., DiCarlo, J., Satya, R. V., Peng, Q. & Wang, Y. Comparison of somatic mutation calling methods in amplicon and whole exome sequence data. BMC Genomics 15, 244 (2014).","journal-title":"BMC Genomics"},{"key":"934_CR62","doi-asserted-by":"publisher","first-page":"bbab186","DOI":"10.1093\/bib\/bbab186","volume":"22","author":"M Diossy","year":"2021","unstructured":"Diossy, M. et al. Strand orientation bias detector to determine the probability of FFPE sequencing artifacts. Brief. Bioinform. 22, bbab186 (2021).","journal-title":"Brief. Bioinform."},{"key":"934_CR63","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1093\/nar\/gkq1034","volume":"39","author":"DA Korona","year":"2011","unstructured":"Korona, D. A., LeCompte, K. G. & Pursell, Z. F. The high fidelity and unique error signature of human DNA polymerase \u03b5. Nucleic Acids Res. 39, 1763\u20131773 (2011).","journal-title":"Nucleic Acids Res."},{"key":"934_CR64","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1373\/clinchem.2014.223040","volume":"61","author":"H Do","year":"2015","unstructured":"Do, H. & Dobrovic, A. Sequence artifacts in DNA from formalin-fixed tissues: causes and strategies for minimization. Clin. Chem. 61, 64\u201371 (2015).","journal-title":"Clin. Chem."},{"key":"934_CR65","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.gde.2020.10.007","volume":"66","author":"CD Robles-Espinoza","year":"2021","unstructured":"Robles-Espinoza, C. D., Mohammadi, P., Bonilla, X. & Gutierrez-Arcelus, M. Allele-specific expression: applications in cancer and technical considerations. Curr. Opin. Genet. Dev. 66, 10\u201319 (2021).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"934_CR66","doi-asserted-by":"crossref","unstructured":"Jiang, J. et al. Identification of hub genes associated with melanoma development by comprehensive bioinformatics analysis. Front. Oncol. 11, 621430 (2021).","DOI":"10.3389\/fonc.2021.621430"},{"key":"934_CR67","doi-asserted-by":"publisher","unstructured":"Yudina, A. & Kotlov, N. BostonGene\/Somatic_reference_standards: Somatic reference for SNV\/INDEL and CNV. Zenodo https:\/\/doi.org\/10.5281\/ZENODO.15261589 (2025).","DOI":"10.5281\/ZENODO.15261589"},{"key":"934_CR68","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.celrep.2015.12.050","volume":"14","author":"NDL Owens","year":"2016","unstructured":"Owens, N. D. L. et al. Measuring absolute RNA copy numbers at high temporal resolution reveals transcriptome kinetics in development. Cell Rep. 14, 632\u2013647 (2016).","journal-title":"Cell Rep."},{"key":"934_CR69","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1038\/nbt.2957","volume":"32","author":"SEQC\/MAQC-III Consortium.","year":"2014","unstructured":"SEQC\/MAQC-III Consortium. A comprehensive assessment of RNA-seq accuracy, reproducibility and information content by the sequencing quality control consortium. Nat. Biotechnol. 32, 903\u2013914 (2014).","journal-title":"Nat. Biotechnol."},{"key":"934_CR70","doi-asserted-by":"publisher","first-page":"e0170632","DOI":"10.1371\/journal.pone.0170632","volume":"12","author":"A Esteve-Codina","year":"2017","unstructured":"Esteve-Codina, A. et al. A comparison of RNA-Seq results from paired formalin-fixed paraffin-embedded and fresh-frozen glioblastoma tissue samples. PLoS ONE 12, e0170632 (2017).","journal-title":"PLoS ONE"},{"key":"934_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-018-4761-3","volume":"19","author":"N Bossel Ben-Moshe","year":"2018","unstructured":"Bossel Ben-Moshe, N. et al. mRNA-seq whole transcriptome profiling of fresh frozen versus archived fixed tissues. BMC Genomics 19, 419 (2018).","journal-title":"BMC Genomics"},{"key":"934_CR72","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1073\/pnas.0809444106","volume":"106","author":"PC Boutros","year":"2009","unstructured":"Boutros, P. C. et al. Prognostic gene signatures for non-small-cell lung cancer. Proc. Natl. Acad. Sci. USA 106, 2824\u20132828 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"934_CR73","doi-asserted-by":"publisher","first-page":"9972","DOI":"10.1111\/jcmm.15601","volume":"24","author":"M Bao","year":"2020","unstructured":"Bao, M., Zhang, L. & Hu, Y. Novel gene signatures for prognosis prediction in ovarian cancer. J. Cell. Mol. Med. 24, 9972\u20139984 (2020).","journal-title":"J. Cell. Mol. Med."},{"key":"934_CR74","doi-asserted-by":"publisher","first-page":"102964","DOI":"10.1016\/j.critrevonc.2020.102964","volume":"151","author":"NR Latha","year":"2020","unstructured":"Latha, N. R. et al. Gene expression signatures: a tool for analysis of breast cancer prognosis and therapy. Crit. Rev. Oncol. Hematol. 151, 102964 (2020).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"934_CR75","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.3390\/biomedicines10081866","volume":"10","author":"E Rabushko","year":"2022","unstructured":"Rabushko, E. et al. Experimentally deduced criteria for detection of clinically relevant fusion 3\u2019 oncogenes from FFPE bulk RNA sequencing data. Biomedicines 10, 1866 (2022).","journal-title":"Biomedicines"},{"key":"934_CR76","doi-asserted-by":"crossref","unstructured":"Deng, W. et al. Fusion gene detection using whole-exome sequencing data in cancer patients. Front. Genet. 13, 820493 (2022).","DOI":"10.3389\/fgene.2022.820493"},{"key":"934_CR77","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1038\/labinvest.2015.83","volume":"95","author":"C Walther","year":"2015","unstructured":"Walther, C. et al. Gene fusion detection in formalin-fixed paraffin-embedded benign fibrous histiocytomas using fluorescence in situ hybridization and RNA sequencing. Lab. Investig. J. Tech. Methods Pathol. 95, 1071\u20131076 (2015).","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"934_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09374-9","volume":"10","author":"EE Heyer","year":"2019","unstructured":"Heyer, E. E. et al. Diagnosis of fusion genes using targeted RNA sequencing. Nat. Commun. 10, 1388 (2019).","journal-title":"Nat. Commun."},{"key":"934_CR79","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12920-020-00746-5","volume":"13","author":"L de Schaetzen van Brienen","year":"2020","unstructured":"de Schaetzen van Brienen, L. et al. Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples. BMC Med. Genomics 13, 94 (2020).","journal-title":"BMC Med. Genomics"},{"key":"934_CR80","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1126\/science.aaa1348","volume":"348","author":"NA Rizvi","year":"2015","unstructured":"Rizvi, N. A. et al. Mutational landscape determines sensitivity to PD-1 blockade in non\u2013small cell lung cancer. Science 348, 124\u2013128 (2015).","journal-title":"Science"},{"key":"934_CR81","doi-asserted-by":"publisher","first-page":"2500","DOI":"10.1056\/NEJMc1713444","volume":"377","author":"M Yarchoan","year":"2017","unstructured":"Yarchoan, M., Hopkins, A. & Jaffee, E. M. Tumor mutational burden and response rate to PD-1 inhibition. N. Engl. J. Med. 377, 2500\u20132501 (2017).","journal-title":"N. Engl. J. Med."},{"key":"934_CR82","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","volume":"371","author":"A Snyder","year":"2014","unstructured":"Snyder, A. et al. Genetic basis for clinical response to CTLA-4 blockade in melanoma. N. Engl. J. Med. 371, 2189\u20132199 (2014).","journal-title":"N. Engl. J. Med."},{"key":"934_CR83","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1200\/JCO.18.01798","volume":"37","author":"F Innocenti","year":"2019","unstructured":"Innocenti, F. et al. Mutational analysis of patients with colorectal cancer in CALGB\/SWOG 80405 identifies new roles of microsatellite instability and tumor mutational burden for patient outcome. J. Clin. Oncol. 37, 1217\u20131227 (2019).","journal-title":"J. Clin. Oncol."},{"key":"934_CR84","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/JCO.2005.01.086","volume":"23","author":"S Popat","year":"2005","unstructured":"Popat, S., Hubner, R. & Houlston, R. S. Systematic review of microsatellite instability and colorectal cancer prognosis. J. Clin. Oncol. 23, 609\u2013618 (2005).","journal-title":"J. Clin. Oncol."},{"key":"934_CR85","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s40425-019-0647-4","volume":"7","author":"L Fancello","year":"2019","unstructured":"Fancello, L., Gandini, S., Pelicci, P. G. & Mazzarella, L. Tumor mutational burden quantification from targeted gene panels: major advancements and challenges. J. Immunother. Cancer 7, 183 (2019).","journal-title":"J. Immunother. Cancer"},{"key":"934_CR86","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","volume":"578","author":"LA Aaltonen","year":"2020","unstructured":"Aaltonen, L. A. et al. Pan-cancer analysis of whole genomes. Nature 578, 82\u201393 (2020).","journal-title":"Nature"},{"key":"934_CR87","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1038\/s41586-019-1689-y","volume":"575","author":"P Priestley","year":"2019","unstructured":"Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. Nature 575, 210\u2013216 (2019).","journal-title":"Nature"},{"key":"934_CR88","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"Cancer Genome Atlas Research Network.","year":"2013","unstructured":"Cancer Genome Atlas Research Network. et al. The Cancer Genome Atlas Pan-Cancer Analysis Project. Nat. Genet. 45, 1113\u20131120 (2013).","journal-title":"Nat. Genet."},{"key":"934_CR89","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/biomedicines8050114","volume":"8","author":"M Sorokin","year":"2020","unstructured":"Sorokin, M. et al. RNA sequencing in comparison to immunohistochemistry for measuring cancer biomarkers in breast cancer and lung cancer specimens. Biomedicines 8, 114 (2020).","journal-title":"Biomedicines"},{"key":"934_CR90","doi-asserted-by":"publisher","unstructured":"Kushnarev, V. et al. 143 Correlating RNA-seq detection and IHC staining of potential antibody-drug conjugate (ADC) targets: HER3, HER2, TROP2, Nectin4, and aFLR. in Regular and Young Investigator Award Abstracts A163\u2013A163 (Journal for ImmunoTherapy of Cancer, :https:\/\/doi.org\/10.1136\/jitc-2023-SITC2023.0143 (2023).","DOI":"10.1136\/jitc-2023-SITC2023.0143"},{"key":"934_CR91","doi-asserted-by":"publisher","first-page":"e111516","DOI":"10.1371\/journal.pone.0111516","volume":"9","author":"AJ Radenbaugh","year":"2014","unstructured":"Radenbaugh, A. J. et al. RADIA: RNA and DNA integrated analysis for somatic mutation detection. PLoS ONE 9, e111516 (2014).","journal-title":"PLoS ONE"},{"key":"934_CR92","doi-asserted-by":"publisher","DOI":"10.1093\/gigascience\/gix122","volume":"7","author":"L Neums","year":"2018","unstructured":"Neums, L. et al. VaDiR: an integrated approach to Variant Detection in RNA. GigaScience 7, gix122 (2018).","journal-title":"GigaScience"},{"key":"934_CR93","first-page":"42","volume":"34","author":"P Shi","year":"2019","unstructured":"Shi, P., Chen, C. & Yao, Y. Correlation between HER-2 gene amplification or protein expression and clinical pathological features of breast cancer. Cancer Biother. Radiopharm. 34, 42\u201346 (2019).","journal-title":"Cancer Biother. Radiopharm."},{"key":"934_CR94","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/sj.bjc.6601703","volume":"90","author":"J Blancato","year":"2004","unstructured":"Blancato, J., Singh, B., Liu, A., Liao, D. J. & Dickson, R. B. Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses. Br. J. Cancer 90, 1612\u20131619 (2004).","journal-title":"Br. J. Cancer"},{"key":"934_CR95","doi-asserted-by":"publisher","first-page":"4487","DOI":"10.1093\/nar\/gkw282","volume":"44","author":"NS Latysheva","year":"2016","unstructured":"Latysheva, N. S. & Babu, M. M. Discovering and understanding oncogenic gene fusions through data intensive computational approaches. Nucleic Acids Res. 44, 4487\u20134503 (2016).","journal-title":"Nucleic Acids Res."},{"key":"934_CR96","doi-asserted-by":"publisher","first-page":"13076","DOI":"10.1073\/pnas.1716483114","volume":"114","author":"ER Kastenhuber","year":"2017","unstructured":"Kastenhuber, E. R. et al. DNAJB1\u2013PRKACA fusion kinase interacts with \u03b2-catenin and the liver regenerative response to drive fibrolamellar hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA 114, 13076\u201313084 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"934_CR97","doi-asserted-by":"publisher","first-page":"177-IN9","DOI":"10.1593\/neo.07822","volume":"10","author":"SA Tomlins","year":"2008","unstructured":"Tomlins, S. A. et al. Role of the TMPRSS2-ERG gene fusion in prostate cancer. Neoplasia 10, 177-IN9 (2008).","journal-title":"Neoplasia"},{"key":"934_CR98","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.3390\/cancers12082104","volume":"12","author":"M Al-Jundi","year":"2020","unstructured":"Al-Jundi, M., Thakur, S., Gubbi, S. & Klubo-Gwiezdzinska, J. Novel targeted therapies for metastatic thyroid cancer\u2014a comprehensive review. Cancers 12, 2104 (2020).","journal-title":"Cancers"},{"key":"934_CR99","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.lungcan.2021.06.002","volume":"160","author":"B Melosky","year":"2021","unstructured":"Melosky, B. et al. The rapidly evolving landscape of novel targeted therapies in advanced non-small cell lung cancer. Lung Cancer 160, 136\u2013151 (2021).","journal-title":"Lung Cancer"},{"key":"934_CR100","doi-asserted-by":"publisher","first-page":"3076","DOI":"10.1200\/JCO.2023.41.16_suppl.3076","volume":"41","author":"K Chernyshov","year":"2023","unstructured":"Chernyshov, K. et al. Aggregated analysis of 1000 patients with cancer to assess the benefits of integrated whole exome and whole transcriptome sequencing. J. Clin. Oncol. 41, 3076\u20133076 (2023).","journal-title":"J. Clin. Oncol."},{"key":"934_CR101","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/ped4.12314","volume":"6","author":"F Peymani","year":"2022","unstructured":"Peymani, F., Farzeen, A. & Prokisch, H. RNA sequencing role and application in clinical diagnostic. Pediatr. Investig. 6, 29\u201335 (2022).","journal-title":"Pediatr. Investig."},{"key":"934_CR102","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.3390\/pharmaceutics15082141","volume":"15","author":"L Rakicevic","year":"2023","unstructured":"Rakicevic, L. DNA and RNA molecules as a foundation of therapy strategies for treatment of cardiovascular diseases. Pharmaceutics 15, 2141 (2023).","journal-title":"Pharmaceutics"},{"key":"934_CR103","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.trecan.2019.02.006","volume":"5","author":"D Lau","year":"2019","unstructured":"Lau, D., Bobe, A. M. & Khan, A. A. RNA sequencing of the tumor microenvironment in precision cancer immunotherapy. Trends Cancer 5, 149\u2013156 (2019).","journal-title":"Trends Cancer"},{"key":"934_CR104","doi-asserted-by":"publisher","DOI":"10.1038\/d41573-024-00064-w","author":"P Flynn","year":"2024","unstructured":"Flynn, P., Suryaprakash, S., Grossman, D., Panier, V. & Wu, J. The antibody-drug conjugate landscape. Nat. Rev. Drug Discov. https:\/\/doi.org\/10.1038\/d41573-024-00064-w (2024).","journal-title":"Nat. Rev. Drug Discov."},{"key":"934_CR105","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/nrg.2016.10","volume":"17","author":"SA Byron","year":"2016","unstructured":"Byron, S. A., Van Keuren-Jensen, K. R., Engelthaler, D. M., Carpten, J. D. & Craig, D. W. Translating RNA sequencing into clinical diagnostics: opportunities and challenges. Nat. Rev. Genet. 17, 257\u2013271 (2016).","journal-title":"Nat. Rev. Genet."},{"key":"934_CR106","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.3390\/ijms21103718","volume":"21","author":"F Zito Marino","year":"2020","unstructured":"Zito Marino, F. et al. NTRK fusions, from the diagnostic algorithm to innovative treatment in the era of precision medicine. Int. J. Mol. Sci. 21, 3718 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"934_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52000-3","volume":"9","author":"MJ McCabe","year":"2019","unstructured":"McCabe, M. J. et al. Development and validation of a targeted gene sequencing panel for application to disparate cancers. Sci. Rep. 9, 17052 (2019).","journal-title":"Sci. Rep."},{"key":"934_CR108","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1093\/bioinformatics\/btu356","volume":"30","author":"H Li","year":"2014","unstructured":"Li, H. Toward better understanding of artifacts in variant calling from high-coverage samples. Bioinforma. Oxf. Engl. 30, 2843\u20132851 (2014).","journal-title":"Bioinforma. Oxf. Engl."},{"key":"934_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/srep36540","volume":"6","author":"L Cai","year":"2016","unstructured":"Cai, L., Yuan, W., Zhang, Z., He, L. & Chou, K.-C. In-depth comparison of somatic point mutation callers based on different tumor next-generation sequencing depth data. Sci. Rep. 6, 36540 (2016).","journal-title":"Sci. Rep."},{"key":"934_CR110","doi-asserted-by":"publisher","first-page":"e0170843","DOI":"10.1371\/journal.pone.0170843","volume":"12","author":"H LaDuca","year":"2017","unstructured":"LaDuca, H. et al. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels. PLoS ONE 12, e0170843 (2017).","journal-title":"PLoS ONE"},{"key":"934_CR111","doi-asserted-by":"publisher","first-page":"e0151664","DOI":"10.1371\/journal.pone.0151664","volume":"11","author":"AB Kr\u00f8ig\u00e5rd","year":"2016","unstructured":"Kr\u00f8ig\u00e5rd, A. B., Thomassen, M., L\u00e6nkholm, A.-V., Kruse, T. A. & Larsen, M. J. Evaluation of nine somatic variant callers for detection of somatic mutations in exome and targeted deep sequencing data. PLoS ONE 11, e0151664 (2016).","journal-title":"PLoS ONE"},{"key":"934_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-60559-5","volume":"10","author":"Z Chen","year":"2020","unstructured":"Chen, Z. et al. Systematic comparison of somatic variant calling performance among different sequencing depth and mutation frequency. Sci. Rep. 10, 3501 (2020).","journal-title":"Sci. Rep."},{"key":"934_CR113","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.jncc.2022.10.004","volume":"3","author":"H Fang","year":"2023","unstructured":"Fang, H. et al. Tumour mutational burden is overestimated by target cancer gene panels. J. Natl. Cancer Cent. 3, 56\u201364 (2023).","journal-title":"J. Natl. Cancer Cent."},{"key":"934_CR114","doi-asserted-by":"publisher","first-page":"16707","DOI":"10.1002\/cam4.6293","volume":"12","author":"S Bartels","year":"2023","unstructured":"Bartels, S. et al. Concordance in detection of microsatellite instability by PCR and NGS in routinely processed tumor specimens of several cancer types. Cancer Med. 12, 16707\u201316715 (2023).","journal-title":"Cancer Med."},{"key":"934_CR115","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/s43018-019-0008-8","volume":"1","author":"V Anagnostou","year":"2020","unstructured":"Anagnostou, V. et al. Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer. Nat. Cancer 1, 99\u2013111 (2020).","journal-title":"Nat. Cancer"},{"key":"934_CR116","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1002\/1878-0261.13015","volume":"16","author":"D Schou N\u00f8r\u00f8xe","year":"2022","unstructured":"Schou N\u00f8r\u00f8xe, D. et al. Tumor mutational burden and purity adjustment before and after treatment with temozolomide in 27 paired samples of glioblastoma: a prospective study. Mol. Oncol. 16, 206\u2013218 (2022).","journal-title":"Mol. Oncol."},{"key":"934_CR117","doi-asserted-by":"crossref","unstructured":"Masood, D. et al. Evaluation of somatic copy number variation detection by NGS technologies and bioinformatics tools on a hyper-diploid cancer genome. Genome Biol. 25, 163 (2024).","DOI":"10.1186\/s13059-024-03294-8"},{"key":"934_CR118","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93878-2","volume":"11","author":"V Gordeeva","year":"2021","unstructured":"Gordeeva, V. et al. Benchmarking germline CNV calling tools from exome sequencing data. Sci. Rep. 11, 14416 (2021).","journal-title":"Sci. Rep."},{"key":"934_CR119","doi-asserted-by":"publisher","first-page":"6070","DOI":"10.1158\/1078-0432.CCR-17-0972","volume":"23","author":"G Seed","year":"2017","unstructured":"Seed, G. et al. Gene copy number estimation from targeted next-generation sequencing of prostate cancer biopsies: analytic validation and clinical qualification. Clin. Cancer Res. 23, 6070\u20136077 (2017).","journal-title":"Clin. Cancer Res."},{"key":"934_CR120","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"934_CR121","doi-asserted-by":"publisher","first-page":"16910","DOI":"10.1073\/pnas.1009843107","volume":"107","author":"P Van Loo","year":"2010","unstructured":"Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl. Acad. Sci. USA 107, 16910\u201316915 (2010).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"934_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-021-01059-x","volume":"14","author":"AK Singh","year":"2021","unstructured":"Singh, A. K. et al. Detecting copy number variation in next generation sequencing data from diagnostic gene panels. BMC Med. Genomics 14, 214 (2021).","journal-title":"BMC Med. Genomics"},{"key":"934_CR123","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nm.4333","volume":"23","author":"A Zehir","year":"2017","unstructured":"Zehir, A. et al. Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients. Nat. Med. 23, 703\u2013713 (2017).","journal-title":"Nat. Med."},{"key":"934_CR124","unstructured":"Bagaev, A. & BostonGene Corporation. Clinical and analytical validation of a combined RNA and DNA exome assay. NCBI (2024)."},{"key":"934_CR125","doi-asserted-by":"publisher","unstructured":"Bagaev, A. & BostonGene Corporation. Clinical and analytical validation of a combined RNA and DNA exome assay across a large tumor cohort: dataset. https:\/\/doi.org\/10.5281\/zenodo.15261029 (2025).","DOI":"10.5281\/zenodo.15261029"}],"container-title":["Communications Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00934-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00934-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T19:02:36Z","timestamp":1750100556000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43856-025-00934-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1038\/s43856-025-00934-3","relation":{},"ISSN":["2730-664X"],"issn-type":[{"value":"2730-664X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"9 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing interests: Jochen Lennerz is the Chief Scientific Officer, and Alexander Bagaev is the Chief Product Officer at BostonGene Corporation. All authors were employees of BostonGene Corporation when the study was performed. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"236"}}